Ex parte CALABRESI et al. - Page 2




              Appeal No. 1996-3866                                                                                     
              Application 08/087,957                                                                                   


                     Claim 14 is illustrative of the claims on appeal and reads as follows:                            
                     14.   A method of treating a mammal suffering from carcinoma to inhibit growth of                 
              said carcinoma which comprises administering to said mammal effective doses of                           
              3'-azido-3'-deoxythymidine and methotrexate, wherein said 3'-azido-3'-deoxythymidine                     
              and said methotrexate are administered within a 48 hour time period, and are more                        
              effective than the combined effects of separate administration of 3'-azido-3'-                           
              deoxythymidine and methotrexate.                                                                         


              The prior art reference relied upon by the examiner is:                                                  
              Minor, Proceedings of ASCO, Vol. 7, No. 4, Abstract No. 16, 1988.                                        


              Ground of Rejection                                                                                      
                     Claims 14-15 and 17-20 stand rejected under 35 U.S.C. § 103 as obvious over                       
              Minor.                                                                                                   
                                                    DISCUSSION                                                         
                     In reaching our decision in this appeal, we have given consideration to the                       
              appellants’ specification and claims, to the applied prior art reference, and to the                     
              respective positions articulated by the appellants and the examiner.                                     




                                                          2                                                            





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007